- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
JAMA Study Finds Existing Blood Pressure Drugs May Prevent Epilepsy - Video
|
Overview
Stanford Medicine researchers and their colleagues have discovered that a class of drugs already on the market to lower blood pressure appears to reduce adults’ risk of developing epilepsy.
The study, published in JAMA Neurology, suggested that the drugs, called angiotensin receptor blockers, could prevent epilepsy in people at highest risk of the disease, including older adults who have had strokes.
Epilepsy, often diagnosed in childhood, also affects over 1% of people over 65, with seizures disrupting brain function and causing various symptoms. In older adults, stroke is the leading risk factor for epilepsy, with 10% of stroke survivors experiencing seizures within five years. Vascular disease and chronic high blood pressure further increase the risk.
While anti-seizure medications control epilepsy after diagnosis, no drugs currently prevent it in high-risk individuals. Recent studies, however, suggest that certain blood pressure medications might help prevent seizures by reducing inflammation, particularly in cases following stroke or traumatic brain injuries, which can trigger epilepsy.
In the study, researchers analysed data from 2.2 million adults diagnosed with high blood pressure who were prescribed at least one blood pressure medication and did not have epilepsy.
They found that individuals taking angiotensin receptor blockers had a 20% to 30% lower risk of developing epilepsy compared to those taking other blood pressure drugs. This reduced risk remained even when patients with strokes were excluded from the analysis, indicating that the lower epilepsy rates were not solely due to a decreased risk of stroke.
“All blood pressure medications likely reduce the risk of epilepsy since high blood pressure contributes to the disorder. Controlling blood pressure through medication and lifestyle changes can lower epilepsy risk. However, new research suggests that angiotensin receptor blockers might be more effective than other antihypertensives in reducing this risk. In the study, 14% of participants took angiotensin receptor blockers, while the majority used other blood pressure medications such as beta blockers, calcium channel blockers, and ACE inhibitors,” said the authors.
Reference: Wen X, Otoo MN, Tang J, et al. Angiotensin Receptor Blockers for Hypertension and Risk of Epilepsy. JAMA Neurol. Published online June 17, 2024. doi:10.1001/jamaneurol.2024.1714
Speakers
Anshika Mishra is a dedicated scholar pursuing a Masters in Biotechnology, driven by a profound passion for exploring the intersection of science and healthcare. Having embarked on this academic journey with a passion to make meaningful contributions to the medical field, Anshika joined Medical Dialogues in 2023 to further delve into the realms of healthcare journalism.